Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Chromosomal Instability in Monitoring the Course of Ovarian High-grade Serous Carcinoma

NCT05310357 is registered in ClinicalTrials.gov with Lei Li as lead sponsor.

NCT NCT05310357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05310357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Chromosomal Instability in Monitoring the Course of Ovarian High-grade Serous Carcinoma
Lead sponsor
Lei Li
Phase
Observational
Overall status
Unknown status
Start date
March 26, 2022
Completion date
March 26, 2024
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chromosomal instability, epithelial ovarian cancer, high-grade serous ovarian carcinoma, minimal residual lesions, overall survival, progression-free survival, somatic copy number distortion, survival outcomes